Role of Inflammation in Psychiatric Disorders in Patients With Cutaneous Lupus

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

May 5, 2017

Primary Completion Date

October 24, 2018

Study Completion Date

October 24, 2018

Conditions
Skin Restricted LupusPsychiatric Disorders
Interventions
BIOLOGICAL

Biological dosage from plasma

The purpose of this study is to determine the role of inflammation in the high prevalence of psychiatric disorders in skin-restricted lupus (SRL) patients. SRL is an inflammatory disease. Inflammation can lead to a decrease in the synthesis of neurotransmitters via the activation of the IDO enzyme and to induce the synthesis of neurotoxic molecules (kynurenin pathway). This leads to the development of psychiatric disorders.

Trial Locations (1)

63003

CHU Clermont-Ferrand, Clermont-Ferrand

All Listed Sponsors
collaborator

Société Française de Cardiologie

OTHER

lead

University Hospital, Clermont-Ferrand

OTHER

NCT03125083 - Role of Inflammation in Psychiatric Disorders in Patients With Cutaneous Lupus | Biotech Hunter | Biotech Hunter